Tag:
malaria
Latest Headlines
Latest Headlines
Counterfeit drugs threaten strides against malaria
While it is the discovery of counterfeit Avastin that is drawing the headlines, the vast majority of counterfeit drugs are being pawned off on the poor in undeveloped areas of Asia and Africa. While victims there pay the health cost, there is an indirect cost to developed countries that often underwrite efforts to eradicate disease in the undeveloped world.
Crowdsourcing tool tapped to spot malaria
Designed at UCLA with the non-scientist in mind, a game allows players to separate healthy from infected blood cells to diagnose malaria.
Scripps begins world's largest computer-based project against malaria
Malaria may have lost big when IBM's ( $IBM ) Watson supercomputer won Jeopardy! in February. Scientists from the Scripps Research Institute in La Jolla, CA have garnered a portion of Watson's...
Ranbaxy earns a rare approval for new malaria treatment
Indian pharma companies have a well-earned reputation for being good at creating cheap knockoffs of branded drugs. The copy-cat expertise has done them little good, though, when it comes to
GSK malaria vax shows promising results
Mosquirix (RTS,S/AS01E), an experimental malaria vaccine from GlaxoSmithKline, provides African children with long-lasting protection and reduces the risk of infection by the parasite that causes
Ranbaxy claims big success with mid-stage malaria drug
While traditional therapies for treating malaria have been steadily losing steam, India's Ranbaxy says that it has nailed positive mid-stage data for a new drug that promises to open a whole new
AZ will open compound library to malaria researchers
The non-profit Medicines for Malaria Venture has just landed another Big Pharma backer . AstraZeneca says that it will open up the books on some 500,000 chemical compounds to help researchers track
Seattle BioMed initiates malaria vax trial
Seattle Biomedical Research Institute said it has officially started the first human clinical trial of its malaria vaccine candidate. The trial will assess the safety of a genetically engineered
Study: Pyramax works as well as Coartem for malaria
Pyramax, an experimental once-a-day malaria drug developed by Korea's Shin Poong Pharmaceutical and the Medicines for Malaria Venture, works just as well as Novartis' twice-daily pill Coartem,
Genocea teams with military on malaria vax research
With the help of a $2.7 million grant from the U.S. Army Medical Research and Materiel Command, Genocea Biosciences will collaborate with the Naval Medical Research Center to identify antigens that
